Overview


According to FutureWise analysis the market for ambulatory cardiac monitoring devices in 2023 is US$ 6.38 billion, and is expected to reach US$ 7.79 billion by 2031 at a CAGR of 10.60%.

Ambulatory cardiac monitoring devices are portable medical devices used to continuously monitor a patient's heart activity outside of a clinical setting. These devices are essential for diagnosing and managing various cardiovascular conditions, including arrhythmias, heart failure, and ischemic heart disease. Unlike traditional in-office monitoring, ambulatory devices allow for extended monitoring periods, ranging from 24 hours to several weeks, providing a more comprehensive assessment of a patient's heart health. The recorded data can be later analysed by healthcare professionals to detect abnormal heart rhythms, assess treatment effectiveness, and make informed decisions regarding patient care. Additionally, these devices offer the convenience of monitoring heart activity during a patient's daily routines, avoiding the need for frequent hospital visits.

Advancements in technology have led to more sophisticated and user-friendly ambulatory cardiac monitoring devices. Many of these devices now feature wireless connectivity, enabling remote monitoring and real-time transmission of data to healthcare providers. This facilitates prompt intervention in case of any cardiac abnormalities, leading to improved patient outcomes. Cardiologists are increasingly using ambulatory cardiac monitoring devices as the prevalence of cardiovascular diseases rises and telemedicine and remote patient monitoring become more common. These devices are essential for enhancing patient care and reducing the burden on healthcare facilities by enabling early detection and proactive management of cardiovascular conditions, which is a top priority for healthcare systems.

FutureWise Market Research has published a report that provides an insightful analysis of ambulatory cardiac monitoring devices market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that ambulatory cardiac monitoring devices market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Medtronic
  • Abbott
  • GE Healthcare
  • Philips Healthcare
  • Hill-Rom
  • Medicomp
  • Schiller
  • Spacelabs Healthcare
  • Applied Cardiac Systems
  • iRhythm
  • BioTelemetry
  • Medicalgorithmics
  • Boston Scientific Corporation
  • LifeWatch AG
  • MediLynx

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments by the Key Players in the Ambulatory Cardiac Monitoring Devices Market:

  • In February 2021, Philips has made a strategic acquisition by taking over BioTelemetry, Inc., a leading provider of cardiac monitoring and diagnostics in the United States. This move will significantly enhance Philips' existing portfolio of cardiac care products, with the integration of BioTelemetry's cutting-edge solutions like Holter monitoring for short- and long-term coverage, Mobile Cardiac Outpatient Telemetry, and Event Recorder solutions.

The ambulatory cardiac monitoring market has been significantly impacted by COVID-19, as in-office visits decreased and remote patient monitoring through cardiac implantable devices became more prevalent. This resulted in increased demand for implantable cardiac devices and contributed to market growth. Post-pandemic, the adoption rate of ambulatory cardiac monitoring is expected to rise, driven by the growing prevalence of heart diseases, an aging population susceptible to coronary heart diseases, and technological advancements in cardiac monitoring devices. The extensive usage of ambulatory cardiac monitoring devices is also supported by the increasing number of cardiovascular procedures. Key market players have launched advanced products and strategic initiatives, such as AliveCor's acquisition of CardioLabs, to strengthen their services for patients' prescribed monitoring devices. However, the high costs associated with monitoring and stringent regulatory procedures may act as constraints to market growth. Despite these challenges, the increasing prevalence of heart diseases and the launch of innovative products are expected to drive the ambulatory cardiac monitoring market's growth in the foreseeable future.

By Type

  • Event Monitors
    • Pre Symptom Loop
    • Post Symptom Loop
  • Mobile Cardiac Telemetry
  • ECG
    • Resting ECG
    • Stress ECG
    • Holter Monitors
  • Implantable Loop Recorders(ILR)
  • Echocardiogram
  • Others

By Application

  • Hospitals
  • Ambulatory Care Centers
  • Clinics
  • Home Healthcare
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The ambulatory cardiac monitoring market in North America is expected to experience significant growth due to various factors. These include the increasing prevalence of cardiovascular diseases, advancements in technology, and favorable government initiatives. Furthermore, it is evaluated that the market will grow due to the rising number of elderly individuals and the introduction of new products, such as Medilynx's continuous ECG streaming patent and Vital Connect's VitalPatch RTM. Overall, the demand for effective ambulatory cardiac monitoring solutions is increasing, which supports the growth of the market in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Ambulatory Cardiac Monitoring Devices Market By Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Ambulatory Cardiac Monitoring Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Ambulatory Cardiac Monitoring Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Ambulatory Cardiac Monitoring Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Ambulatory Cardiac Monitoring Devices Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Event Monitors
         1.1. Pre Symptom Loop
         1.2. Post Symptom Loop
        2. Mobile Cardiac Telemetry
        3. ECG
         3.1. Resting ECG
         3.2. Stress ECG
         3.3. Holter Monitors
        4. Implantable Loop Recorders(ILR)
        5. Echocardiogram
        6. Others

  • 8.   Ambulatory Cardiac Monitoring Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Ambulatory Care Centers
        3. Clinics
        4. Home Healthcare
        5. Others

  • 9.   North America Ambulatory Cardiac Monitoring Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Ambulatory Cardiac Monitoring Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Ambulatory Cardiac Monitoring Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Ambulatory Cardiac Monitoring Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Medtronic
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. GE Healthcare
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Philips Healthcare
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Hill-Rom
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Medicomp
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Schiller
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Spacelabs Healthcare
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Applied Cardiac Systems
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
          10. iRhythm
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
          11. BioTelemetry
         11.1. Company Overview
         11.2. Targeted Antigen Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
          12. Medicalgorithmics
         12.1. Company Overview
         12.2. Targeted Antigen Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
          13. Boston Scientific Corporation
         13.1. Company Overview
         13.2. Targeted Antigen Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
          14. LifeWatch AG
         14.1. Company Overview
         14.2. Targeted Antigen Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
          15. MediLynx
         15.1. Company Overview
         15.2. Targeted Antigen Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client

Related Market

Cardiac Monitoring and Cardiac Rhythm Management Devices Market

Read More

Cardiac Monitoring And Diagnostic Devices Market

Read More

Continuous Cardiac Monitoring Devices Market

Read More

Cardiac Monitoring Devices Market

Read More

Implantable Cardiac Monitors Market

Read More
Partner

Our Clients